Edges in Network
| Network | GSE16391_egf1520 - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | MYL5 |
| Upstream (Parents) |
|---|
| (<<) APLN → MYL5 |
| (<<) BZW2 → MYL5 |
| (<<) CTSF → MYL5 |
| (<<) EFNB2 → MYL5 |
| (<<) EMG1 → MYL5 |
| (<<) FLJ35390 → MYL5 |
| (<<) HDAC8 → MYL5 |
| (<<) IDI1 → MYL5 |
| (<<) LOC441245 → MYL5 |
| (<<) LOC642031 → MYL5 |
| (<<) LOC92249 → MYL5 |
| (<<) PKIG → MYL5 |
| (<<) PRKX → MYL5 |
| (<<) RPS6KA1 → MYL5 |
| (<<) SERPINB1 → MYL5 |
| (<<) SPR → MYL5 |
| (<<) STK16 → MYL5 |
| (<<) TRIB3 → MYL5 |
| (<<) TUBA1B → MYL5 |
| Downstream (Children) |
|---|
| MYL5 → CEACAM1 (>>) |
| MYL5 → DYNC1LI2 (>>) |
| MYL5 → GNAS (>>) |
| MYL5 → MST1R (>>) |
| MYL5 → NMU (>>) |
